Buserelin0 vendors competing
No vendor pricing available for this peptide yet.
Research details
Buserelin — research data
Regulatory statusApproved (various countries)
NCAA D1Banned
Overview
About Buserelin
Mechanism of action
GnRH agonist; nasal or injectable formulations
Safety profile
Hot flashes, sexual dysfunction, bone density loss · Approved for prostate cancer, endometriosis; hot flashes, bone loss with long-term use; well-established
Related pages